Sonus Pharmaceuticals, Inc

Sonus Pharmaceuticals Refines Strategic Initiatives
Mar 25, 2008

9.5 KB

Mar 25, 2008 (PrimeNewswire via COMTEX News Network) -- Company Focuses on SN2310 and External Initiatives; Ends Internal Discovery Effort Cash Burn Further Reduced BOTHELL, Wash., March 25, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it...

Sonus Pharmaceuticals Announces Fourth Quarter and Year End Results Conference Call and Presentation At WBBA Invest Northwest
Feb 20, 2008

8.2 KB

BOTHELL, Wash., Feb 20, 2008 (PrimeNewswire via COMTEX News Network) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS), an oncology drug development company, today announced that it will release financial results for the fourth quarter of fiscal 2007 ended December 31, 2007, on March 5, 2008 at 1:30 P.M. PT/4:30 P.M. ET. Michael Martino, President a...

Sonus Pharmaceuticals Announces Receipt of NASDAQ Notification
Nov 7, 2007

7.7 KB

BOTHELL, Wash., Nov 7, 2007 (PrimeNewswire via COMTEX News Network) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has received a notice from The Nasdaq Stock Market ("Nasdaq") dated November 5, 2007, indicating that the Company does not comply with the $1.00 minimum bid price requirement for continued listing under Marketplac...

Sonus Pharmaceuticals Engages Ferghana Partners Inc. as Strategic Advisor
Oct 22, 2007

8.9 KB

BOTHELL, Wash., Oct 22, 2007 (PrimeNewswire via COMTEX News Network) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has engaged Ferghana Partners Inc. ("Ferghana") as its advisor to assist the Company in identifying, evaluating and pursuing alternative strategies to maximize shareholder value. Ferghana is an international prov...